Your browser doesn't support javascript.
loading
A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Duska, L R; Krasner, C N; O'Malley, D M; Hays, J L; Modesitt, S C; Mathews, C A; Moore, K N; Thaker, P H; Miller, A; Purdy, C; Zamboni, W C; Lucas, A T; Supko, J G; Schilder, R J.
Afiliação
  • Duska LR; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: lduska@virginia.edu.
  • Krasner CN; Dana Farber Cancer Institute, Boston, MA, USA.
  • O'Malley DM; James Comprehensive Cancer Center and Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Hays JL; James Comprehensive Cancer Center and Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Modesitt SC; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Mathews CA; Women and Infants Hospital, Providence, RI, USA.
  • Moore KN; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Thaker PH; Washington University School of Medicine, St. Louis, MO, USA.
  • Miller A; Roswell Park Comprehensive Center, Buffalo, NY, USA.
  • Purdy C; Roswell Park Comprehensive Center, Buffalo, NY, USA.
  • Zamboni WC; UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center of Nanotechnology Excellence, University of North Carolina, Chapel Hill, NC, USA.
  • Lucas AT; UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, Carolina Center of Nanotechnology Excellence, University of North Carolina, Chapel Hill, NC, USA.
  • Supko JG; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA 20114, USA.
  • Schilder RJ; Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadephia, PA, USA.
Gynecol Oncol ; 160(3): 688-695, 2021 03.
Article em En | MEDLINE | ID: mdl-33390325
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Paclitaxel / Neoplasias das Tubas Uterinas / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Paclitaxel / Neoplasias das Tubas Uterinas / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article